A randomized phase III trial comparing mitomycin-C plus short-term doxifluridine (Mf) versus mitomycin-C plus long-term doxifluridine plus cisplatin (MFP) after curative resection of advanced gastric cancer (AMC 0201) (NCT00296335)

被引：0
|
作者：
Chang, H.
Kang, Y.
Min, Y.
Zang, D.
Kim, G.
Yang, D.
Jang, S.
Yook, J.
Oh, S.
Kim, B.
机构：
[1] Asan Medcl Ctr, Seoul, South Korea
[2] Ulsan Univ Hosp, Ulsan, South Korea
[3] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4531
引用
收藏
页数：1
相关论文
共 38 条
  • [31] Short-term outcomes of capecitabine plus oxaliplatin versus S-1 plus oxaliplatin as adjuvant chemotherapies for advanced gastric cancer after laparoscopic gastrectomy and D2 resection: A prospective, multicenter randomized, controlled clinical trial
    Yan, Y.
    Lu, L.
    Wang, X.
    Wang, D.
    Huang, Q.
    Zhao, Q.
    Liu, T.
    Fu, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S111 - S111
  • [32] Long-term outcome of neoadjuvant mFOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: A multicenter, randomized phase III trial.
    Zhang, Jianwei
    Chi, Pan
    Lan, Ping
    Cui, Long
    Wei, Hongbo
    Zhao, Ren
    Huang, Zhongcheng
    Zhang, Hao
    Cai, Yue
    Wang, Jianping
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Pujol, Jean-Louis
    Paz-Ares, Luis
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Bidoli, Paolo
    Corral, Jesus
    San Antonio, Belen
    Chouaki, Nadia
    John, William
    Zimmermann, Annamaria
    Visseren-Grul, Carla
    Gridelli, Cesare
    CLINICAL LUNG CANCER, 2014, 15 (06) : 418 - 425
  • [34] Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy
    Bellmunt, J.
    Fougeray, R.
    Rosenberg, J. E.
    von der Maase, H.
    Schutz, F. A.
    Salhi, Y.
    Culine, S.
    Choueiri, T. K.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1466 - 1472
  • [35] Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer; short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG 0501)
    Terashima, M.
    Iwasaki, Y.
    Mizusawa, J.
    Katayama, H.
    Nakamura, K.
    Katai, H.
    Yoshikawa, T.
    Ito, S.
    Kaji, M.
    Kimura, Y.
    Hirao, M.
    Yamada, M.
    Kurita, A.
    Takagi, M.
    Goto, M.
    Takagane, A.
    Yabuzaki, H.
    Hirabayashi, N.
    Sano, T.
    Sasako, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S406 - S406
  • [36] Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)
    Terashima, Masanori
    Iwasaki, Yoshiaki
    Mizusawa, Junki
    Katayama, Hiroshi
    Nakamura, Kenichi
    Katai, Hitoshi
    Yoshikawa, Takaki
    Ito, Yuichi
    Kaji, Masahide
    Kimura, Yutaka
    Hirao, Motohiro
    Yamada, Makoto
    Kurita, Akira
    Takagi, Masakazu
    Boku, Narikazu
    Sano, Takeshi
    Sasako, Mitsuru
    Takagane, Akinori
    Koeda, Keisuke
    Teshima, Shin
    Fujitani, Tsuneaki
    Fukushima, Norimasa
    Matsushita, Naoyuki
    Kazuo, Hase
    Kawashima, Yoshiyuki
    Kinoshita, Takahiro
    Inokuchi, Mikito
    Ueno, Masanori
    Wada, Ikuo
    Yabusaki, Hiroshi
    Kawauchi, Yasuyuki
    Miyashita, Kaoru
    Ito, Seiji
    Hata, Hiroaki
    Doki, Yuichiro
    Yasuda, Takushi
    Omori, Ken
    Goto, Masahiro
    Imamura, Hiroshi
    GASTRIC CANCER, 2019, 22 (05) : 1044 - 1052
  • [37] Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)
    Masanori Terashima
    Yoshiaki Iwasaki
    Junki Mizusawa
    Hiroshi Katayama
    Kenichi Nakamura
    Hitoshi Katai
    Takaki Yoshikawa
    Yuichi Ito
    Masahide Kaji
    Yutaka Kimura
    Motohiro Hirao
    Makoto Yamada
    Akira Kurita
    Masakazu Takagi
    Narikazu Boku
    Takeshi Sano
    Mitsuru Sasako
    Gastric Cancer, 2019, 22 : 1044 - 1052
  • [38] Hyperfractionated Accelerated Radiation Therapy (HART) of 70.6 Gy With Concurrent 5-FU/Mitomycin C Is Superior to HART of 77.6 Gy Alone in Locally Advanced Head and Neck Cancer: Long-term Results of the AR0 95-06 Randomized Phase III Trial
    Budach, Volker
    Stromberger, Carmen
    Poettgen, Christoph
    Baumann, Michael
    Budach, Wilfried
    Grabenbauer, Gerhard
    Marnitz, Simone
    Olze, Heidi
    Wernecke, Klaus-Dieter
    Ghadjar, Pirus
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (05): : 916 - 924
1234